Literature DB >> 27681694

Breast Cancer Epidemiology and Risk Factors.

Kristin Rojas1, Ashley Stuckey.   

Abstract

Between the years 2010 and 2012, the lifetime probability of developing female breast cancer was 12.3%, or approximately 1 in 8. Worldwide, breast cancer is the most common cancer in women. Survival is increasing. Between 2005 and 2011, the 5-year relative survival was found to be 89%. This is thought to be due to both the increase in utilization of population-wide screening, as well as advances in treatment. Less than 10% of breast cancers can be attributed to an inherited genetic mutation. Breast cancer is more commonly associated with environmental, reproductive, and lifestyle factors, some of which are potentially modifiable.

Entities:  

Mesh:

Year:  2016        PMID: 27681694     DOI: 10.1097/GRF.0000000000000239

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  92 in total

Review 1.  Epithelial-Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: Mediators of Breast Cancer Therapy Resistance.

Authors:  Alex J Gooding; William P Schiemann
Journal:  Mol Cancer Res       Date:  2020-06-05       Impact factor: 5.852

2.  Knowledge regarding fertility preservation in cancer patients: a population-based survey among Brazilian people during the Pink October awareness event.

Authors:  Mauricio B Chehin; Tatiana Cs Bonetti; Paulo C Serafini; Eduardo LA Motta
Journal:  JBRA Assist Reprod       Date:  2017-06-01

3.  Relationship between matrix metalloproteinase-9 and some clinicopathological prognostic factors of breast carcinoma.

Authors:  Fereshteh Mohammadizadeh; Mahsa Bagherian-Dehkordia
Journal:  Am J Clin Exp Immunol       Date:  2021-02-15

4.  Downregulation of microRNA-30c-5p was responsible for cell migration and tumor metastasis via COTL1-mediated microfilament arrangement in breast cancer.

Authors:  Bei Pei; Tongyang Li; Qi Qian; Wenqiang Fan; Xiao He; Yulan Zhu; Lingyun Xu
Journal:  Gland Surg       Date:  2020-06

5.  Lipid Intake and Breast Cancer Risk: Is There a Link? A New Focus and Meta-Analysis.

Authors:  Massimo Lodi; Amélie Kiehl; Fei Lin Qu; Victor Gabriele; Catherine Tomasetto; Carole Mathelin
Journal:  Eur J Breast Health       Date:  2022-04-01

6.  Correlation Between Contrast-enhanced Ultrasound Characteristics (Qualitative and Quantitative) and Pathological Prognostic Factors in Breast Cancer.

Authors:  Irene Vraka; Evangelia Panourgias; Emmanouil Sifakis; Andreas Koureas; Petros Galanis; Dionysios Dellaportas; Athanasios Gouliamos; Aristides Antoniou
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

7.  Choosing high-risk screening vs. surgery and the effect of treatment modality on anxiety and breast-specific sensuality in BRCA mutation carriers.

Authors:  Kristin E Rojas; Elizabeth Butler; Julie Gutierrez; Rebecca Kwait; Jessica Laprise; Jennifer Scalia Wilbur; Sarah Spinette; Christina A Raker; Katina Robison; Robert Legare; Jennifer Gass; Ashley Stuckey
Journal:  Gland Surg       Date:  2019-06

8.  The Effects of Pre-Treatment and Post-Treatment of Thymol against tert-Butyl Hydroperoxide (t-BHP) Cytotoxicity in MCF-7 Cell Line and Fibroblast Derived Foreskin.

Authors:  Afsaneh Dashtaki; Soleiman Mahjoub; Ebrahim Zabihi; Roghayeh Pourbagher
Journal:  Rep Biochem Mol Biol       Date:  2020-10

9.  Investigation of SRP9 protein expression in breast cancer.

Authors:  Gizem Erdoğan; Didem Can Trabulus; Canan Kelten Talu; Mehmet Güven
Journal:  Mol Biol Rep       Date:  2021-11-02       Impact factor: 2.316

10.  Assessing Biomarkers of Breast Cancer Risk in Underserved Women in a Midwestern County.

Authors:  Marla A DeWitt; Ivana T Croghan; Celine M Vachon; Thomas D Thacher; Marcia R Venegas Pont; Lonzetta Neal; Daniela L Stan; Sarah M Jenkins; Sandhya Pruthi
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.